ranolazine
RxNorm concept 35829, ingredient (in).
- RxCUI
- 35829
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/35829 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Ranexa (BN, has tradename)
- Aspruzyo (BN, has tradename)
- ranolazine 500 MG (SCDC, ingredient of)
- ranolazine Extended Release Oral Tablet (SCDF, ingredient of)
- ranolazine 1000 MG (SCDC, ingredient of)
- ranolazine Oral Product (SCDG, ingredient of)
- ranolazine Pill (SCDG, ingredient of)
- ranolazine Granule Product (SCDG, ingredient of)
- ranolazine Oral Granules (SCDF, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 35829 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/35829 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 35829. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.